Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Debt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity RatioFCF MarginGross MarginInvested CapitalNet MarginOperating MarginReturn on Invested CapitalReturn on Sales

Dr Reddys Laboratories (RDY) Operating Margin (2016 - 2025)

Historic Operating Margin for Dr Reddys Laboratories (RDY) over the last 17 years, with Q4 2025 value amounting to 16.32%.

  • Dr Reddys Laboratories' Operating Margin fell 60800.0% to 16.32% in Q4 2025 from the same period last year, while for Dec 2025 it was 26.93%, marking a year-over-year decrease of 23200.0%. This contributed to the annual value of 22.09% for FY2025, which is 21700.0% down from last year.
  • Latest data reveals that Dr Reddys Laboratories reported Operating Margin of 16.32% as of Q4 2025, which was down 60800.0% from 20.75% recorded in Q1 2025.
  • Dr Reddys Laboratories' Operating Margin's 5-year high stood at 26.14% during Q1 2023, with a 5-year trough of 2.76% in Q4 2021.
  • For the 5-year period, Dr Reddys Laboratories' Operating Margin averaged around 20.79%, with its median value being 21.89% (2024).
  • Per our database at Business Quant, Dr Reddys Laboratories' Operating Margin plummeted by -133400bps in 2021 and then skyrocketed by 169300bps in 2022.
  • Quarter analysis of 5 years shows Dr Reddys Laboratories' Operating Margin stood at 2.76% in 2021, then skyrocketed by 613bps to 19.69% in 2022, then grew by 22bps to 23.93% in 2023, then decreased by -6bps to 22.4% in 2024, then dropped by -27bps to 16.32% in 2025.
  • Its Operating Margin was 16.32% in Q4 2025, compared to 20.75% in Q1 2025 and 22.4% in Q4 2024.